Given the previous data on CACNA1A, in which ectopic expression of a microRNA is able to perturb IRES function [28], this is extremely important and represents a starting point for the development of this type of therapeutic for treatment-resistant HER2-amplified cancers. The gene discussed is ERBB2; the disease is cancer.